Skip to main content
. 2019 Jul 17;17(4):1038–1043. doi: 10.5114/aoms.2019.86622

Figure 4.

Figure 4

MiR-130b knockdown improved doxorubicin sensitivity of doxorubicin-resistant cells through negatively regulating CYLD. *p < 0.05 vs. miR-NC(–) + sh-NC, #p < 0.05 vs. 130b(–) + sh-NC